Highlands Oncology Group Is First In Western World Studying a New Therapy For Specific Cancers Fayetteville, AR - May 22, 2015 - (Newswire.com)
Highlands Oncology Group (HOG), a northwest Arkansas based cancer treatment and research facility, is the first research site, in the Western hemisphere and Europe, to study a new targeted oral therapy for triple negative breast cancer, gastric cancer and non-Hodgkin’s lymphoma.
The therapy targets c-myc, a well-established oncogene. An oncogene is a mutated form of a gene involved in normal cell growth which may cause the growth of cancer cells, according to the National Cancer Institute.
The investigative oral therapy has the potential to become a new treatment option for patients in the region.
“It is exciting to have another drug which may provide a new target option for our patients with triple negative breast cancer," said J. Thaddeus Beck, a leading physician and co-founder of HOG.
HOG is committed to the advancement of breast cancer treatment and will present further research on triple-negative breast cancer at the annual American Society of Clinical Oncology meeting this year in Chicago.
Aside from skin cancer, breast cancer is the most common cancer among American women, according to the American Cancer Society (ACS). About 12 percent of women will develop breast cancer during their lifetime, according to the ACS.
As the leading cancer treatment and research facility in Northwest Arkansas, HOG is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
###
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer every day.
For more information visit www.HighlandsOncologyGroup.com.
Contact Info:The Artist Evolution
203 1753 N College Ave.
Fayetteville
AR 72703
United States
Press Release Service by Newswire.com
Original Source: NWA Oncology Group Breaks Ground In Targeted Breast Cancer Research
